Community Pharmacists and Opioid Misuse

Completed · Not applicable

Conditions studied: Opioid Misuse

In brief

Opioid medication misuse and overdose have reached epidemic proportions in the US. Community pharmacy is a potentially valuable resource for addressing opioid medication misuse. This study will manualize and establish the feasibility, acceptability, and clinical effect of a community pharmacist-led intervention aimed at: improving opioid mediation regimen adherence, eliminating misuse, connecting patients to additional care, and safeguarding against overdose.

Key facts

Study ID

NCT03149718

Run by

University of Utah

People needed

46

Starts

2017-09-15

Expected to finish

2019-06-01

Last updated by the study team

2019-10-14

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Opioid Misuse
• ≥18 years
• English speaking

You may not qualify if…

• Are pregnant (given potential pre/post-natal opioid use complications among pregnant women/offspring)
• Cannot provide collateral contact information for ≥2 contact persons (to ensure consistent contact/follow up)
• Do not have a reliable landline or mobile phone to be contacted by study staff
• Are only filling buprenorphine (given some formulations are not indicated for pain)
• Plan to leave the area for an extended period of time in the next 3 months
• Have had a psychotic and/or manic episode in the last 30 days

Where it is running

• Falk Pharmacy — Pittsburgh, Pennsylvania, United States
• Medicine Shoppe — Somerset, Pennsylvania, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.